Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

SHA:600566 Revenue

Hubei Jumpcan Pharmaceutical had revenue of 1.12B CNY in the quarter ending June 30, 2026, a decrease of -8.38%. This brings the company's revenue in the last twelve months to 5.80B, down -13.86% year-over-year. In the year 2025, Hubei Jumpcan Pharmaceutical had annual revenue of 6.22B, down -22.43%. That makes Hubei Jumpcan Pharmaceutical the 8,266th largest company in the world by revenue and 1,256th in China.

• Revenue (ttm): 5.80B
• Revenue Growth: -13.86%
• P/S Ratio: 4.24
• Revenue / Employee: 1.40M
• Employees: 4,137
• Market Cap: 24.61B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.22B	-1.80B	-22.43%
Dec 31, 2024	8.02B	-1.64B	-16.96%
Dec 31, 2023	9.65B	658.17M	7.32%
Dec 31, 2022	9.00B	1.37B	17.90%
Dec 31, 2021	7.63B	1.47B	23.77%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 9, 2026

Data Sources Report a data error